10:30 às 12:00 - IAS/SBC-DA Joint Sessions: Triglyceride-rich lipoproteins: relevance in atherogenesis and therapeutic perspectives
10:45 às 11:00 - Pemafibrate: a selective PPAR-α modulator to reduce plasma triglyceride levels: role in preventing atherosclerosis?
